223 related articles for article (PubMed ID: 25569308)
1. A high-throughput screen reveals new small-molecule activators and inhibitors of pantothenate kinases.
Sharma LK; Leonardi R; Lin W; Boyd VA; Goktug A; Shelat AA; Chen T; Jackowski S; Rock CO
J Med Chem; 2015 Feb; 58(3):1563-8. PubMed ID: 25569308
[TBL] [Abstract][Full Text] [Related]
2. Probing the ligand preferences of the three types of bacterial pantothenate kinase.
Guan J; Barnard L; Cresson J; Hoegl A; Chang JH; Strauss E; Auclair K
Bioorg Med Chem; 2018 Dec; 26(22):5896-5902. PubMed ID: 30429095
[TBL] [Abstract][Full Text] [Related]
3. Identification of Specific and Nonspecific Inhibitors of Bacillus anthracis Type III Pantothenate Kinase (PanK).
Shapiro JA; Varga JJ; Parsonage D; Walton W; Redinbo MR; Ross LJ; White EL; Bostwick R; Wuest WM; Claiborne A; Goldberg JB
ChemMedChem; 2019 Jan; 14(1):78-82. PubMed ID: 30376607
[TBL] [Abstract][Full Text] [Related]
4. Modulation of pantothenate kinase 3 activity by small molecules that interact with the substrate/allosteric regulatory domain.
Leonardi R; Zhang YM; Yun MK; Zhou R; Zeng FY; Lin W; Cui J; Chen T; Rock CO; White SW; Jackowski S
Chem Biol; 2010 Aug; 17(8):892-902. PubMed ID: 20797618
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors.
Virga KG; Zhang YM; Leonardi R; Ivey RA; Hevener K; Park HW; Jackowski S; Rock CO; Lee RE
Bioorg Med Chem; 2006 Feb; 14(4):1007-20. PubMed ID: 16213731
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for substrate binding and the catalytic mechanism of type III pantothenate kinase.
Yang K; Strauss E; Huerta C; Zhang H
Biochemistry; 2008 Feb; 47(5):1369-80. PubMed ID: 18186650
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Structure-Activity Relationship Study of (
Manz TD; Sivakumaren SC; Ferguson FM; Zhang T; Yasgar A; Seo HS; Ficarro SB; Card JD; Shim H; Miduturu CV; Simeonov A; Shen M; Marto JA; Dhe-Paganon S; Hall MD; Cantley LC; Gray NS
J Med Chem; 2020 May; 63(9):4880-4895. PubMed ID: 32298120
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A.
Schröder D; Rehbach C; Seyffarth C; Neuenschwander M; Kries JV; Windhorst S
Biochem Biophys Res Commun; 2013 Sep; 439(2):228-34. PubMed ID: 23981806
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Mycobacterium tuberculosis pantothenate kinase vulnerability through target knockdown and mechanistically diverse inhibitors.
Reddy BK; Landge S; Ravishankar S; Patil V; Shinde V; Tantry S; Kale M; Raichurkar A; Menasinakai S; Mudugal NV; Ambady A; Ghosh A; Tunduguru R; Kaur P; Singh R; Kumar N; Bharath S; Sundaram A; Bhat J; Sambandamurthy VK; Björkelid C; Jones TA; Das K; Bandodkar B; Malolanarasimhan K; Mukherjee K; Ramachandran V
Antimicrob Agents Chemother; 2014 Jun; 58(6):3312-26. PubMed ID: 24687493
[TBL] [Abstract][Full Text] [Related]
10. Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.
Jung ME; Byun BJ; Kim HM; Lee JY; Park JH; Lee N; Son YH; Choi SU; Yang KM; Kim SJ; Lee K; Kim YC; Choi G
Bioorg Med Chem Lett; 2016 Jun; 26(11):2719-23. PubMed ID: 27106709
[TBL] [Abstract][Full Text] [Related]
11. LipE guided discovery of isopropylphenyl pyridazines as pantothenate kinase modulators.
Sharma LK; Yun MK; Subramanian C; Tangallapally R; Jackowski S; Rock CO; White SW; Lee RE
Bioorg Med Chem; 2021 Dec; 52():116504. PubMed ID: 34814071
[TBL] [Abstract][Full Text] [Related]
12. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
[TBL] [Abstract][Full Text] [Related]
13. Protocols for the Design of Kinase-focused Compound Libraries.
Jacoby E; Wroblowski B; Buyck C; Neefs JM; Meyer C; Cummings MD; van Vlijmen H
Mol Inform; 2018 May; 37(5):e1700119. PubMed ID: 29116686
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a type III pantothenate kinase: insight into the mechanism of an essential coenzyme A biosynthetic enzyme universally distributed in bacteria.
Yang K; Eyobo Y; Brand LA; Martynowski D; Tomchick D; Strauss E; Zhang H
J Bacteriol; 2006 Aug; 188(15):5532-40. PubMed ID: 16855243
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of pantothenate kinase in Anopheles stephensi suppresses pantothenate levels with minimal impacts on mosquito fitness.
Thakre N; Simão Gurge RM; Isoe J; Kivi H; Strickland J; Delacruz LR; Rodriguez AM; Haney R; Sadeghi R; Joy T; Chen M; Luckhart S; Riehle MA
Insect Biochem Mol Biol; 2022 Oct; 149():103834. PubMed ID: 36087890
[TBL] [Abstract][Full Text] [Related]
16. Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ.
Rutaganira FU; Fowler ML; McPhail JA; Gelman MA; Nguyen K; Xiong A; Dornan GL; Tavshanjian B; Glenn JS; Shokat KM; Burke JE
J Med Chem; 2016 Mar; 59(5):1830-9. PubMed ID: 26885694
[TBL] [Abstract][Full Text] [Related]
17. The design, annotation, and application of a kinase-targeted library.
Xi H; Lunney EA
Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening.
Piala AT; Akella R; Potts MB; Dudics-Giagnocavo SA; He H; Wei S; White MA; Posner BA; Goldsmith EJ
Bioorg Med Chem Lett; 2016 Aug; 26(16):3923-7. PubMed ID: 27426302
[TBL] [Abstract][Full Text] [Related]
19. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
20. Characterization and validation of Entamoeba histolytica pantothenate kinase as a novel anti-amebic drug target.
Nurkanto A; Jeelani G; Yamamoto T; Naito Y; Hishiki T; Mori M; Suematsu M; Shiomi K; Hashimoto T; Nozaki T
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):125-136. PubMed ID: 29518650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
